OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 108 filers reported holding OCULAR THERAPEUTIX INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $44 | -99.9% | 15,814 | +19.1% | 0.00% | -20.0% |
| Q3 2022 | $55,000 | -73.9% | 13,274 | -37.0% | 0.01% | -80.0% |
| Q3 2021 | $211,000 | -37.2% | 21,066 | -11.1% | 0.02% | -26.5% |
| Q2 2021 | $336,000 | -1.8% | 23,702 | +13.8% | 0.03% | -12.8% |
| Q1 2021 | $342,000 | +12.5% | 20,828 | -47.9% | 0.04% | -20.4% |
| Q3 2020 | $304,000 | +192.3% | 39,974 | +90.7% | 0.05% | +145.0% |
| Q1 2020 | $104,000 | +23.8% | 20,960 | -0.6% | 0.02% | +33.3% |
| Q4 2018 | $84,000 | -56.9% | 21,077 | +0.1% | 0.02% | -67.4% |
| Q1 2017 | $195,000 | -34.1% | 21,062 | -40.6% | 0.05% | -41.8% |
| Q4 2016 | $296,000 | – | 35,458 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |